Cargando…
The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3
INTRODUCTION: Perampanel is a highly selective and noncompetitive α‐amino‐3 ‐hydroxy‐5‐methyl‐4‐isoxazole propionate receptor (AMPAR) antagonist, which has been used as an orally administered antiepileptic drug in more than 55 countries. Recently, perampanel was shown to exert neuroprotective effect...
Autores principales: | Chen, Tao, Liu, Wen‐Bo, Qian, Xiao, Xie, Ke‐Liang, Wang, Yu‐Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804923/ https://www.ncbi.nlm.nih.gov/pubmed/33421349 http://dx.doi.org/10.1111/cns.13580 |
Ejemplares similares
-
Perampanel, an AMPAR antagonist, alleviates experimental intracerebral hemorrhage-induced brain injury via necroptosis and neuroinflammation
por: Yang, Lixiang, et al.
Publicado: (2021) -
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam
por: Zolkowska, Dorota, et al.
Publicado: (2021) -
Therapeutic potential of AMPA receptor antagonist perampanel against cerebral ischemia: beyond epileptic disorder
por: Suda, Satoshi, et al.
Publicado: (2019) -
Evidence for AMPAR association
por: Tuma, Rabiya S.
Publicado: (2005) -
Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro
por: Li, Chang-Xiang, et al.
Publicado: (2019)